---

• Deerfield, IL


• Contact:
  Jeff Himawan
  
• www.horizonpharma.com
• Formerly Known As: Horizon Therapeutics
• Acquisition
• Acquired by: Rival Raptor
• Exit date: September 16, 2016

Related News

• Horizon Pharma Announces U.S. Food and Drug Administration Acceptance of LODOTRA (R) New Drug Application for Review for the Treatment of Rheumatoid Arthritis
• Investors Set Their Sights on Horizon Pharma
• Annals of the Rheumatic Diseases Publishes Pivotal Phase 3 Study Demonstrating Efficacy and Safety of RAYOS(R) in Combination With DMARD Therapy in Rheumatoid Arthritis Patients
• Horizon Pharma Receives U.S. Patent Allowance for DUEXIS (ibuprofen/famotidine)